RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000075.xml
Semin Respir Crit Care Med 2022; 43(04): 541-551
DOI: 10.1055/s-0042-1747938
DOI: 10.1055/s-0042-1747938
Review Article
Bronchoscopic Lung Volume Reduction for Emphysema: Review and Update
Theodoor David Koster
1
Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
,
Marlies Van Dijk
1
Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
,
Dirk-Jan Slebos
1
Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
› Institutsangaben
Abstract
In carefully selected patients with severe chronic obstructive pulmonary disease, characterized by emphysema and hyperinflation, lung volume reduction is an option to reduce lung hyperinflation, improve lung function, quality of life, and exercise capacity. Currently, there are several bronchoscopic and surgical treatment options to achieve lung volume reduction. It is important to carefully phenotype these patients, to select the optimal treatment option, with consideration of possible adverse events or contraindications, and it is highly recommended to discuss these treatment strategies in a multidisciplinary team. The treatment with one-way endobronchial valves has been investigated most extensively and more data are available regarding the treatment of more “marginal cases,” or subsequent lung volume reduction surgery. Other bronchoscopic lung volume reduction options include treatment with coils, thermal vapor ablation, and sclerosant agents. In this review, we aim to summarize the current clinical evidence on the bronchoscopic lung volume reduction therapies and important aspects regarding optimal patient selection.
Keywords
bronchoscopic lung volume reduction - lung volume reduction surgery - emphysema - COPD - endobronchial valves - patient selectionPublikationsverlauf
Artikel online veröffentlicht:
13. Mai 2022
© 2021. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Singh D, Agusti A, Anzueto A. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J 2019; 53 (05) 1900164
- 2 van Geffen WH, Slebos DJ, Herth FJ, Kemp SV, Weder W, Shah PL. Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysis. Lancet Respir Med 2019; 7 (04) 313-324
- 3 Herth FJF, Slebos DJ, Criner GJ, Valipour A, Sciurba F, Shah PL. Endoscopic lung volume reduction: an expert panel recommendation—update 2019. Respiration 2019; 97 (06) 548-557
- 4 Klooster K, Slebos DJ. Endobronchial valves for the treatment of advanced emphysema. Chest 2021; 159 (05) 1833-1842
- 5 Slebos DJ, Shah PL, Herth FJ, Valipour A. Endobronchial valves for endoscopic lung volume reduction: best practice recommendations from expert panel on endoscopic lung volume reduction. Respiration 2017; 93 (02) 138-150
- 6 Herth FJ, Eberhardt R, Gompelmann D. et al. Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment. Eur Respir J 2013; 41 (02) 302-308
- 7 Klooster K, ten Hacken NH, Hartman JE, Kerstjens HA, van Rikxoort EM, Slebos DJ. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med 2015; 373 (24) 2325-2335
- 8 Toma TP, Hopkinson NS, Hillier J. et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003; 361 (9361): 931-933
- 9 Snell GI, Holsworth L, Borrill ZL. et al. The potential for bronchoscopic lung volume reduction using bronchial prostheses: a pilot study. Chest 2003; 124 (03) 1073-1080
- 10 Davey C, Zoumot Z, Jordan S. et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet 2015; 386 (9998): 1066-1073
- 11 Herth FJ, Noppen M, Valipour A. et al; International VENT Study Group. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012; 39 (06) 1334-1342
- 12 Valipour A, Slebos DJ, Herth F. et al; IMPACT Study Team. Endobronchial valve therapy in patients with homogeneous emphysema. results from the IMPACT study. Am J Respir Crit Care Med 2016; 194 (09) 1073-1082
- 13 Criner GJ, Delage A, Voelker K. et al. Improving lung function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A multicenter, open-label randomized controlled clinical trial. Am J Respir Crit Care Med 2019; 200 (11) 1354-1362
- 14 Criner GJ, Sue R, Wright S. et al; LIBERATE Study Group. A Multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med 2018; 198 (09) 1151-1164
- 15 Kemp SV, Slebos DJ, Kirk A. et al; TRANSFORM Study Team *. A multicenter randomized controlled trial of zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med 2017; 196 (12) 1535-1543
- 16 Sciurba FC, Ernst A, Herth FJ. et al; VENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363 (13) 1233-1244
- 17 Li S, Wang G, Wang C. et al. The REACH Trial: a randomized controlled trial assessing the safety and effectiveness of the Spiration® valve system in the treatment of severe emphysema. Respiration 2019; 97 (05) 416-427
- 18 Klooster K, Koster TD, Ruwwe-Glösenkamp C. et al. An integrative approach of the fissure completeness score and Chartis assessment in endobronchial valve treatment for emphysema. Int J Chron Obstruct Pulmon Dis 2020; 15: 1325-1334
- 19 Koster TD, van Rikxoort EM, Huebner RH. et al. Predicting lung volume reduction after endobronchial valve therapy is maximized using a combination of diagnostic tools. Respiration 2016; 92 (03) 150-157
- 20 Bryant M, Ley S, Eberhardt R. et al. Assessment of the relationship between morphological emphysema phenotype and corresponding pulmonary perfusion pattern on a segmental level. Eur Radiol 2015; 25 (01) 72-80
- 21 Eberhardt R, Gompelmann D, Herth FJ, Schuhmann M. Endoscopic bronchial valve treatment: patient selection and special considerations. Int J Chron Obstruct Pulmon Dis 2015; 10: 2147-2157
- 22 van Dijk M, Sue R, Criner GJ. et al. Expert statement: pneumothorax associated with one-way valve therapy for emphysema: 2020 update. Respiration 2021; 100 (10) 969-978
- 23 Koster TD, Klooster K, Ten Hacken NHT, van Dijk M, Slebos DJ. Endobronchial valve therapy for severe emphysema: an overview of valve-related complications and its management. Expert Rev Respir Med 2020; 14 (12) 1235-1247
- 24 Welling JBA, Hartman JE, Ten Hacken NHT. et al. Chartis measurement of collateral ventilation: conscious sedation versus general anesthesia—a retrospective comparison. Respiration 2018; 96 (05) 480-487
- 25 Welling JBA, Klooster K, Hartman JE. et al. Collateral ventilation measurement using Chartis: procedural sedation vs general anesthesia. Chest 2019; 156 (05) 984-990
- 26 Koster TD, Klooster K, McNamara H. et al. An adjusted and time-saving method to measure collateral ventilation with Chartis. ERJ Open Res 2021; 7 (03) 00191-2021
- 27 Herzog D, Thomsen C, Poellinger A. et al. Outcomes of endobronchial valve treatment based on the precise criteria of an endobronchial catheter for detection of collateral ventilation under spontaneous breathing. Respiration 2016; 91 (01) 69-78
- 28 Fishman A, Fessler H, Martinez F. et al; National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. N Engl J Med 2001; 345 (15) 1075-1083
- 29 van Dijk M, Hartman JE, Klooster K, Ten Hacken NHT, Kerstjens HAM, Slebos DJ. Endobronchial valve treatment in emphysema patients with a very low DLCO. Respiration 2020; 99 (02) 163-170
- 30 Lenga P, Ruwwe-Glösenkamp C, Grah C. et al. Endoscopic lung volume reduction with endobronchial valves in very low D LCO patients: results from the German Registry—Lungenemphysemregister e.V. ERJ Open Res 2021; 7 (01) 00449-2020
- 31 van Dijk M, Klooster K, Ten Hacken NHT, Sciurba F, Kerstjens HAM, Slebos DJ. The effects of lung volume reduction treatment on diffusing capacity and gas exchange. Eur Respir Rev 2020; 29 (158) 190171
- 32 Darwiche K, Karpf-Wissel R, Eisenmann S. et al. Bronchoscopic lung volume reduction with endobronchial valves in low-FEV1 patients. Respiration 2016; 92 (06) 414-419
- 33 Trudzinski FC, Höink AJ, Leppert D. et al. Endoscopic lung volume reduction using endobronchial valves in patients with severe emphysema and very low FEV1. Respiration 2016; 92 (04) 258-265
- 34 Zoumot Z, Kemp SV, Shah PL. Endobronchial valves for emphysema: time to push the envelope?. Respiration 2016; 92 (06) 359-361
- 35 Rötting M, Polke M, Kriegsmann K. et al. Impact of endoscopic valve therapy on hypercapnia in patients with chronic hypercapnic failure based on a severe lung emphysema. Eur Respir J 2020; 56 (Suppl. 64) 3777
- 36 Darwiche K, Aigner C. Clinical management of lung volume reduction in end stage emphysema patients. J Thorac Dis 2018; 10 (Suppl. 23) S2732-S2737
- 37 Klooster K, Hartman JE, van Dijk M, Koster TD, Slebos DJ. Response to endobronchial valve treatment in emphysema patients with moderate hyperinflation. J Bronchology Interv Pulmonol 2021; 28 (01) e14-e17
- 38 Roodenburg SA, Pouwels SD, Slebos DJ. Airway granulation response to lung-implantable medical devices: a concise overview. Eur Respir Rev 2021; 30 (161) 210066
- 39 Roodenburg SA, Klooster K, Hartman JE, Koster TD, van Dijk M, Slebos DJ. Revision bronchoscopy after endobronchial valve treatment for emphysema: indications, findings and outcomes. Int J Chron Obstruct Pulmon Dis 2021; 16: 1127-1136
- 40 Eichhorn ME, Gompelmann D, Hoffmann H. et al. Consolidating lung volume reduction surgery after endoscopic lung volume reduction failure. Ann Thorac Surg 2021; 111 (06) 1858-1865
- 41 Caviezel C, Guglielmetti LC, Ladan M. et al. Lung volume reduction surgery as salvage procedure after previous use of endobronchial valves. Interact Cardiovasc Thorac Surg 2021; 32 (02) 263-269
- 42 Dooms C, Blondeel A, Ceulemans LJ. et al. Lung volume reduction in emphysema: a pragmatic prospective cohort study. ERJ Open Res 2021; 7 (02) 00877-2020
- 43 van Geffen WH, Klooster K, Hartman JE. et al. Pleural adhesion assessment as a predictor for pneumothorax after endobronchial valve treatment. Respiration 2017; 94 (02) 224-231
- 44 Herth FJ, Eberhard R, Gompelmann D, Slebos DJ, Ernst A. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther Adv Respir Dis 2010; 4 (04) 225-231
- 45 Klooster K, Valipour A, Marquette CH. et al. Endobronchial coil system versus standard-of-care medical management in the treatment of subjects with severe emphysema. Respiration 2021; 100 (08) 804-810
- 46 Hartman JE, Shah PL, Sciurba F, Herth FJF, Slebos DJ, Group RS. RENEW Study Group. Endobronchial coils for emphysema: dual mechanism of action on lobar residual volume reduction. Respirology 2020; 25 (11) 1160-1166
- 47 Slebos DJ, Ten Hacken NH, Hetzel M, Herth FJF, Shah PL. Endobronchial coils for endoscopic lung volume reduction: best practice recommendations from an expert panel. Respiration 2018; 96 (01) 1-11
- 48 Sciurba FC, Criner GJ, Strange C. et al; RENEW Study Research Group. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial. JAMA 2016; 315 (20) 2178-2189
- 49 Slebos DJ, Hartman JE, Klooster K. et al. Bronchoscopic coil treatment for patients with severe emphysema: a meta-analysis. Respiration 2015; 90 (02) 136-145
- 50 Shah PL, Zoumot Z, Singh S. et al; RESET trial Study Group. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med 2013; 1 (03) 233-240
- 51 Deslée G, Mal H, Dutau H. et al; REVOLENS Study Group. Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial. JAMA 2016; 315 (02) 175-184
- 52 Herth FJF, Slebos DJ, Shah PL. et al. Protocol of a randomized controlled study of the PneumRx endobronchial coil system versus standard-of-care medical management in the treatment of subjects with severe emphysema (ELEVATE). Respiration 2019; 98 (06) 512-520
- 53 Gompelmann D, Eberhardt R, Ernst A. et al. The localized inflammatory response to bronchoscopic thermal vapor ablation. Respiration 2013; 86 (04) 324-331
- 54 Gompelmann D, Shah PL, Valipour A, Herth FJF. Bronchoscopic thermal vapor ablation: best practice recommendations from an expert panel on endoscopic lung volume reduction. Respiration 2018; 95 (06) 392-400
- 55 Herth FJ, Valipour A, Shah PL. et al. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respir Med 2016; 4 (03) 185-193
- 56 Herth FJ, Gompelmann D, Stanzel F. et al. Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal®). Respiration 2011; 82 (01) 36-45
- 57 Kramer MR, Refaely Y, Maimon N, Rosengarten D, Fruchter O. Bilateral endoscopic sealant lung volume reduction therapy for advanced emphysema. Chest 2012; 142 (05) 1111-1117
- 58 Refaely Y, Dransfield M, Kramer MR. et al. Biologic lung volume reduction therapy for advanced homogeneous emphysema. Eur Respir J 2010; 36 (01) 20-27
- 59 Come CE, Kramer MR, Dransfield MT. et al. A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J 2015; 46 (03) 651-662
- 60 Slebos DJ, Herth F, Koster TD. et al. A modified staged treatment algorithm using the AeriSeal System. Eur Respir J 2020; 56 (Suppl. 64) 1572
- 61 Shah PL, Slebos DJ. Bronchoscopic interventions for severe emphysema: where are we now?. Respirology 2020; 25 (09) 972-980
- 62 Herth FJF, Slebos DJ, Criner GJ, Shah PL. Endoscopic lung volume reduction: an expert panel recommendation—update 2017. Respiration 2017; 94 (04) 380-388
- 63 Hartman JE, Garner JL, Shah PL, Slebos DJ. New bronchoscopic treatment modalities for patients with chronic bronchitis. Eur Respir Rev 2021; 30 (159) 200281
- 64 Eberhardt R, Gerovasili V, Kontogianni K. et al. Endoscopic lung volume reduction with endobronchial valves in patients with severe emphysema and established pulmonary hypertension. Respiration 2015; 89 (01) 41-48
- 65 Goldberg AB, Mazur W, Kalra DK. Pulmonary hypertension: diagnosis, imaging techniques, and novel therapies. Cardiovasc Diagn Ther 2017; 7 (04) 405-417
- 66 van Agteren JE, Carson KV, Tiong LU, Smith BJ. Lung volume reduction surgery for diffuse emphysema. Cochrane Database Syst Rev 2016; 10: CD001001
- 67 van Agteren JE, Hnin K, Grosser D, Carson KV, Smith BJ. Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2017; 2: CD012158
- 68 Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246 (03) 697-722
- 69 Takahashi M, Fukuoka J, Nitta N. et al. Imaging of pulmonary emphysema: a pictorial review. Int J Chron Obstruct Pulmon Dis 2008; 3 (02) 193-204
- 70 Herth FJF, Kirby M, Sieren J. et al. The modern art of reading computed tomography images of the lungs: quantitative CT. Respiration 2018; 95 (01) 8-17
- 71 Labaki WW, Martinez CH, Martinez FJ. et al. The role of chest computed tomography in the evaluation and management of the patient with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2017; 196 (11) 1372-1379
- 72 Friedman PJ. Imaging studies in emphysema. Proc Am Thorac Soc 2008; 5 (04) 494-500
- 73 Lynch DA, Newell JD. Quantitative imaging of COPD. J Thorac Imaging 2009; 24 (03) 189-194
- 74 Welling JBA, Hartman JE, Augustijn SWS. et al. Patient selection for bronchoscopic lung volume reduction. Int J Chron Obstruct Pulmon Dis 2020; 15: 871-881
- 75 Ing A, Sullivan C, Hersch N, Saghaie T, Williamson J. Reversal of collateral ventilation using endobronchial polymer sealant in a patient with emphysema undergoing endoscopic lung volume reduction (ELVR) with valves: a case report and proof of concept. J Bronchology Interv Pulmonol 2020; 27 (01) e14-e16